The 3 randomly selected alternative splicing genes (URI1, MTMR14 and BPTF) were further validated by qPCR in HCC clinical samples and alternative splicing events of these three genes are significantly changed (p < 0.001). Here, BPTF is linked to hepatocellular carcinoma.